The following is an excerpt.
Almost immediately after the Supreme Court ruled that human genes could not be patented, several laboratories announced they, too, would begin offering genetic testing for breast cancer risk, making it likely that that test and others could become more affordable and more widely available.
Read the full story here: After Patent Ruling, Availability of Gene Tests Could Broaden